BioSpace News Archive

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced that management will participate in the Cowen 43nd Annual Healthcare Conference, which is being held March 6-8, 2023, at the Boston Marriott Copley Place in Boston, Massachusetts.

Aural Analytics, Inc., a leader in clinical-grade speech analytics, today announced that its speech analytics platform facilitated differentiation and provided critical insights into the effectiveness of Pridopidine in clinical trials.

Astria Therapeutics, Inc. (Nasdaq:ATXS) presented new STAR-0215 data in two poster presentations at the American Academy of Allergy, Asthma, and Immunology Annual Meeting in San Antonio, Texas that demonstrate early proof-of-concept for STAR-0215’s profile as a long-acting preventative therapy for HAE.

Agilent Technologies Inc. announced their xCELLigence RTCA HT platform now integrates with the BioTek BioSpa 8 Automated Incubator.

Legend Biotech Corporation, a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, announced its participation in the upcoming investor conferences.

ARCA biopharma, Inc., a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, reported 2022 financial results and provided a corporate update.

SELLAS Life Sciences Group, Inc. announced the pricing of its previously announced underwritten public offering of 7,220,217 shares of its common stock and accompanying warrants to purchase up to 7,220,217 shares of common stock at a combined public offering price of $2.77 per share and accompanying warrant.

The International Federation of Pharmaceutical Wholesalers, in partnership with member companies including global healthcare company AmerisourceBergen and IQVIA, a leading provider of advanced analytics and technology solutions, launched an ESG framework and toolkit to serve as a resource for the industry.

Bio-Techne Corporation announced that a newly finalized local coverage determination from National Government Services, Inc., a Medicare Administrative Contractor, includes coverage for the ExoDx™ Prostate Test from Exosome Diagnostics, a Bio-Techne brand.

Living in areas of the United States with higher levels of air pollution is associated with an increased risk of Parkinson’s disease, according to a preliminary study released February 23, 2023, that will be presented at the American Academy of Neurology’s 75th Annual Meeting being held in person in Boston and live online from April 22-27, 2023.